This special issue introduces the emerging contours of a series of large-scale biological research projects, drawing them together in dialogue with each other and in critical debate with the extant rhetorics and practices of 'big science' in biology. The category of 'big biology' is in question from the start. On the one hand, it serves to frame and align the ways in which these projects are being developed and positioned in relation to epistemic ambitions, funding imperatives, research governance, choice and maintenance of infrastructure, geographical scope and social importance, especially within scientific, media and policy narratives. Given the vast amounts of resources (skills, technologies, funding and manpower) directed to contemporary bioscience research, and the growing emphasis in Europe, the USA and elsewhere on funding co-ordinated initiatives and projects, the suggestion that biology is 'big science' increasingly figures in popular characterisations and science policy statements (see for example Weinberg, 1999; Collins et al, 2003; Nass and Stillman, 2003; Esparza and Yamada, 2007; see also Vermeulen, 2010). On the other hand, the idea and operation of an emerging 'big biology' is far from singular and unproblematic, especially given the difficulties in defining what counts as a shift in the scale of research. The range of initiatives covered in this volume immediately attests to its diverse characteristics, and points to further difficulties in attempting to define what is meant by 'big biology' today, and how it differs, if at all, from historical manifestations of large-scale science.
is better. We thus suggest these large-scale initiatives are an inventive re-organisation of the spatiotemporal dynamics governing biological research, which has epistemic, spatial and social implications for the knowledge being produced and for the researchers and experimental subjects (whether human or non-human) included in their scope. Bringing these case studies together allows exploration of why and how this reorganisation of biological research is emerging:
through new forms of governance (Hilgartner), spatial imaginaries (Davies), research infrastructures (Leonelli) and articulations of value (Calvert), and by creating new kinds of moral economies in biology (Frow). Such moral economies define both the inside and the outside of research, facilitating the identification of those and that which is excluded. Looking comparatively across these case studies facilitates analysis of the tensions within and gaps between aspirations, the geographical and biological boundaries that are being set, and the related shifts in how biological phenomena are being apprehended.
Geographical scholarship has pointed to the importance of critically examining the multiple registers of scale at play in key concepts such as maps, models, complex systems and the social constitution of space, which are being reshaped in the practices of 'big biology'.
2 Scalar considerations are central to the organisation of research in 'big biology', the very objects of interest (organisms), and the content of the knowledge produced about them. Three aspects in particular come to the fore. First, there is the centrality of scale to the mapping and modelling aspirations of these different projects in 'big biology'; each case study offers a slightly different resolution to the answer 'what is a biological object?' which do not necessarily articulate easily.
Second, different scales of accountability are critical to the management practices associated with these projects, and particularly to the institutionalisation of new forms of standardisation, evaluation and economisation that are implemented to try and realise the potential from economies of scale for scientific communities, national investments and biological knowledge production. And third, the scalar discourses of 'big biology', which stress the global and largescale, require critical reflection, for such discourses risk obscuring the multiplicity of scientific and material practices, the divergent places and communities, and the contested spatial imaginaries now involved in making up 'big science'. Some of these processes suggest, and in some cases reinforce, hierarchical scales -as in the definition of global standards from local sites;
2 For a critical discussion and review of the concept of scale in geography see Marston et al (2005) , Leitner and Miller (2006) , and Moore (2008) . The relations between scale, size and different orders of complexity have also been a focus of work in STS; see for example Law (2004) and Kwa (2002 others are more horizontally networked -as in the more distributed processes of collecting and curating data. We do not suggest that these biological, managerial or geographical scales pre-exist current developments in the organisation and practice of biological research; the forms of largescale science that emerge from these intersections are precarious achievements and could easily be disrupted by future shifts in the scientific, geopolitical and economic contexts of research.
However, we do suggest that there is a politics of scale requiring empirical analysis, for to change scale, even if only discursively, is to intervene in the distribution of levels of decision-making, power and control (Bulkeley, 2005) . (Leonelli, 2010a) , and demands for short-term returns on translational medicine and research impact (Sunder Rajan and Leonelli, 2013) . Last, but by no means least, there is 'big money' at stake, for the idea of a 'big biology' promises to realise the value of large investments through economies of scale, reallocating funds across different research practices, remaking forms of bio-value, and redistributing roles and rewards within the sciences. Thus despite, or perhaps because of, its discursive imprecision, the continuing use of the term 'big biology' demands critical attention and empirical exploration as an inventive way of defining and organising biological research.
The historical lineages of these claims are also important, for the growing emphasis on 'big biology' is often identified in relation to the legacies of biology's own history, notably the Human Genome Project (HGP), but also in relation to other scientific trajectories, such as the post-war emphasis on 'big physics' (see Kevles, 1997) . As Hilgartner's paper explores, the constitution of the HGP as a project, with identified milestones over time and across space, set up a template and a series of expectations for both the organisation and the evaluation of large-scale bioscience.
This was not the first time the history of the life sciences witnessed an attempt to assemble vast amounts of resources, funding, individual skills, expertises and data productively; think only of Linnaeus' 18 th century botanical networks (Mueller-Wille, 2004) or the International Biological Programme, running from 1964 -1974 (Aronova et al, 2010 . The vision underlying the HGP is also rooted in 20 th -century precedents for the organisation of research around non-human model organisms such as Drosophila (Leonelli and Ankeny, 2012) . We focus on the HGP here because it has come to epitomise a specific template for what counts as a big biological project today, involving (1) the ideation of an epistemic project in biology of value to state funders, and (2) its institutionalisation through the top-down but distributed governance of several competing centres across geographical locations.
With this framework, project management became a central organisational tool for directing the spatio-temporal dynamics and scales of the HGP. The co-ordination of efforts, the evaluation of success, and the demonstration of accountability were achieved by focusing on measurable milestones, or landmarks, through the production of sequence-tagged sites at each genome centre.
Focusing on sequence data as the main result of experimental efforts meant each participating institution could contribute to the overarching effort with the same 'currency', with little regard for qualitative differences in the ways in which each centre produced their data. This in turn meant research was turned into a matter of incremental production, aimed at the aggregation of commensurable and quantifiable masses of data across space, where speed was the main factor in evaluating the success of contributions by each centre. Thereby, speed in data production and dissemination was placed at the centre of the HGP; centres were expected to compete to improve their rates of sequence production. Failure became a matter of managerial logics, defined by assessing the relative performance of centres involved in this 'data race'. If centres did not keep up, they did not get further funding. At the heart of the HGP was thus the mobilisation of a particular conceptualisation of informationalised biology, linked to the transportability, accumulation and acceleration of data-collection procedures. way of conceiving a 'biological project' was not conceptually obvious. In part this is due to the recognition of growing complexity and relationality in post-genomic approaches, which are arguably harder to capture through the incremental accumulation of data, experiments and models, and in part because of the logistical difficulties in sustaining and advancing research through such a top-down approach.
Comparison with earlier academic analyses of 'big science' in the form of physics programmes is also instructive, for it highlights further ambiguities around the notions of scale at work in contemporary 'big biology'. Social scientific accounts of these earlier instantiations of large-scale science often focus on the expensive equipment and centralised facilities of 20 th century physics (e.g. Weinberg, 1967; Hughes, 2002; Galison, 1997; Traweek, 1988) , where the large numbers of people working on projects based around large apparatus function as a visible marker of 'big science'. Particle physics in particular has a long history of orchestrated efforts to generate large quantities of data through centralized experimental set-ups, such as the hadron collider. This phenomenon has been well-documented in the case of CERN (Kriege, 1996; Knorr-Cetina, 1999) . The practices of 'big physics' were dependent on an international migratory workforce, shaped by global governance, and explicitly geopolitical in ambition. Scale emerges from these experimental sites by way of their articulation with national funding priorities and international scientific collaborations. They also depended on the enrolment and integration of very specific sets of experts. Such experts are not easy to integrate, as Galison (1997) and Knorr-Cetina (1999) demonstrate in their discussion of the interactions between theoreticians and experimentalists. But their respective responsibilities are relatively well-defined and they were generally visible to each other. In comparison, contemporary large-scale biology does not function through a single experimental site, but operates through the bureaucratic surveillance of widely distributed and less visible research practices, to include a variety of differently situated forms of expertise. The labours of 'big biology' involve an increasing raft of fieldworkers, the scale of whose contributions are not always discernible to others. The relevant skills and knowledge to tackle problems may also come from any field of the sciences or even the humanities, as demonstrated by the unexpected collaboration between biologists, medics, computer scientists and logicians involved in setting up classification systems for bio-medical databases (Leonelli 2010b). 4 One reason for the fluid mix of skills and scale in large-scale biology projects is the living and lively nature of biological objects. A major task for the life sciences is finding ways to manage the irreducible contingency and emergent properties of organisms, through strategies to reduce and parcel complexity into manageable units, for instance through the use of model organisms and other disciplinary lenses. Yet, and as often pointed out by biologists themselves, this requires constant awareness of the limitations of any one perspective and the willingness to accept that new strategies, ideas and skills might be needed to tackle emerging questions. Scale has long been a key criterion for reduction and for the division of research labour, for instance enabling biologists to distinguish between molecular and cellular levels, or between microbial and macrobial scales of analysis (Dupré, 2011) . In contemporary large-scale biology, the managerial obsession with the 'project' as the basic unit for research organisation acts as a further device to direct and limit the attention of researchers, preventing individual laboratories from 'drifting off' when they encounter something interesting or unexpected. However, any such attempt to compartmentalise and standardise biological processes is necessarily bound to specific short-term research goals. The tensions that emerge between attempts to govern and regulate interactions and divisions of labour between the components of large projects, and the importance of letting individual laboratories explore biological systems in creative and unpredictable ways, are another important characteristic of contemporary 'big science', one that is discussed and problematised in most of the papers in this special issue.
Rhetorics and practices of data sharing, standardisation and milestone-setting mobilise and aggregate biological properties and capacities at different scales, through different means and with different effects. Some of these projects may be bigger and faster than what came before, but the question of whether they are necessarily better is more openly contested. Such questioning is coming from at least three different directions, which we explore in turn. The first is in the encounter between engineering or managerial logics and experimental biological emergence. The second is in the relation between global and local practices in specific experimental settings and individual locales. The third is from the opening out of the ambitions of 'big biology' to a wider set of societal needs, and their transformation into grand challenges.
In relation to the first, the technical and biological logics of investing so heavily in highthroughput techniques may be reaching their limits. This critique was articulated in relation to the HGP, where investments in sequencing came into conflict with norms of discovery-driven science (e.g. Balmer, 1996) , and it is now re-emerging with new strength. New bottlenecks are evident in the co-ordination of large-scale projects that cannot be solved solely by working faster The increasing demand for data integration and collaboration among scientists also has the potential to bring some knowledge communities into closer dialogue and interaction. This is illustrated in a number of the papers, such as in Leonelli's work on different kinds of databases and Davies' research exploring the integration of previously dispersed scientific communities working with mouse models. Yet, as shown Leonelli, and others, the development of 'big biology' also increases entry costs, and is accompanied by continuing debates about the ownership of and access to data, as well as arguments about the spatial location of databases and other resources, resulting in new forms of exclusion and enclosure. 'Big biology' is not only characterised by accelerating spatial and temporal flows of biological throughput, it is also patterned by the spatial, political and economic redistribution of resources across disciplines, researchers and countries, whether seeking to build capacity within the European 'knowledgebased bio-economy' or to increase efficiencies through out-sourcing mundane work. It thus becomes important to highlight the counterpart to the question asked above with reference to the HGP: 'What does it mean not to run a genome centre there?' and to interrogate who, in the context of these asymmetric collaborations, gets to define where is 'here' and 'there'. As Sunder Rajan's commentary points out, the relations between the global and the local in the production of biological knowledge intersect in critically important ways with questions of the transnational and postcolonial (see also Anderson, 2009; Harding, 2011) . collaborative relationships with the scientists and funders of the initiatives they study. The study of the practices of 'big biology' unavoidably includes some form of incorporation and personal investment into those practices, ranging from friendly relations with researchers, which guarantee long-term dialogue and access to laboratories (Davies, Hilgartner), to the involvement in synthetic biology projects as collaborators or as 'ELSI consultants' (Frow, Calvert) , and the appointment to steering committees for the coordination of research efforts (Leonelli) . Even when social dimensions of the research are explicitly sought, for example by incorporating social scientists into the scope of research endeavours such as nanotechnology and synthetic biology, social researchers themselves can occupy a peculiar position, also serving as representatives of the public and proxies for scientific accountability to public funding and society at large (Doubleday, 2007; Calvert and Martin, 2009) . Lezaun elaborates on these questions and their implications in his closing commentary, brining the papers into dialogue with critical literatures on the growth of the project as an organisational form in contemporary capitalism.
In conclusion, 'big biology' is a quite contested and explicitly divisive term, for to recognise something as large-scale research by definition identifies other science as 'small'. As Hilgartner's opening paper explains, the HGP was constituted alongside the simultaneous redefinition of extant molecular biology as 'ordinary biology'. This served the purpose of positioning the HGP as being about resources, rather than a competitor for research funds. Yet, this special issue shows that as ideas and models of large-scale science proliferate and diversify, more people and more projects are being drawn into their scope and the spatial, social and epistemic divisions of labour that they create. The contestations and concerns about 'big biology' continue, both within the community and from its diminishing outside 7 . However, as it grows and diversifies, large-scale bioscience retains these expansionary logics, through forms of accounting that value acceleration and efficiency, and incorporate the social injunction that 'something must be done'. As more and more biological research is brought within the auspices of 'big biology', whether as explicit projects or more expansive grand challenges, there is less and less scope to be left outside its logics and reach, for scientists and perhaps for social scientists too.
